Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
CLINGEN |
Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
|
23572067 |
2013 |
Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
CLINGEN |
Proteomics. Tissue-based map of the human proteome.
|
25613900 |
2015 |
Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
CLINGEN |
Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.
|
19608031 |
2009 |
Cardiomyopathies
|
0.320 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Total Anomalous Pulmonary Venous Return 1
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return.
|
18273862 |
2008 |
Cardiomegaly
|
0.200 |
Biomarker
|
phenotype |
RGD |
Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter.
|
10904011 |
2000 |
Myocardial Reperfusion Injury
|
0.200 |
Biomarker
|
phenotype |
RGD |
Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury.
|
19299913 |
2009 |
Familial dilated cardiomyopathy
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.
|
19525294 |
2009 |
Cardiomyopathy, Dilated
|
0.130 |
Biomarker
|
group |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lipodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myopathy
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Creatine phosphokinase serum increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neutrophil abnormality
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Lipoatrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Keratoderma, Palmoplantar
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Amyotrophic Lateral Sclerosis
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
We found that CARP was aberrantly expressed in atrophic skeletal muscle fibers in ALS.
|
12679596 |
2003 |
Diabetic Nephropathy
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis.
|
17239933 |
2007 |
Glomerulonephritis
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis.
|
17239933 |
2007 |
Congenital Heart Defects
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return.
|
18273862 |
2008 |
Lupus Nephritis
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis.
|
17239933 |
2007 |
Endometriosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
Endometrioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
Hypertrophic Cardiomyopathy
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we investigated whether expression of HCM-associated ANKRD1 mutations affects contraction parameters after gene transfer in engineered heart tissues (EHTs).
|
23572067 |
2013 |